1. Home
  2. CORT vs MANH Comparison

CORT vs MANH Comparison

Compare CORT & MANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$89.23

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Logo Manhattan Associates Inc.

MANH

Manhattan Associates Inc.

HOLD

Current Price

$151.07

Market Cap

8.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
MANH
Founded
1998
1990
Country
United States
United States
Employees
730
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.2B
IPO Year
2001
1998

Fundamental Metrics

Financial Performance
Metric
CORT
MANH
Price
$89.23
$151.07
Analyst Decision
Buy
Buy
Analyst Count
5
11
Target Price
$96.50
$209.73
AVG Volume (30 Days)
957.9K
563.7K
Earning Date
04-30-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.56
EPS
N/A
0.82
Revenue
$761,407,000.00
$131,300,000.00
Revenue This Year
$26.08
$8.10
Revenue Next Year
$26.98
$8.81
P/E Ratio
N/A
$184.24
Revenue Growth
12.79
N/A
52 Week Low
$28.66
$119.06
52 Week High
$91.00
$247.22

Technical Indicators

Market Signals
Indicator
CORT
MANH
Relative Strength Index (RSI) 80.68 62.59
Support Level $76.41 $125.51
Resistance Level N/A $154.19
Average True Range (ATR) 3.76 6.30
MACD -0.09 1.30
Stochastic Oscillator 94.20 88.53

Price Performance

Historical Comparison
CORT
MANH

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About MANH Manhattan Associates Inc.

Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers worldwide.

Share on Social Networks: